Patents Assigned to Lynx Therapeutics, Inc.
  • Patent number: 6831994
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: December 14, 2004
    Assignee: Lynx Therapeutics, inc.
    Inventors: John Bridgham, Kevin Corcoran, George Golda, Michael C. Pallas, Sydney Brenner
  • Patent number: 6806052
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: October 19, 2004
    Assignee: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin P. Corcoran, George S. Golda, Michael C. Pallas, Sydney Brenner
  • Publication number: 20040152658
    Abstract: The present invention provides methods and materials related to immediate early genes. Specifically, the invention provides isolated immediate early gene nucleic acid, cells that contain isolated immediate early gene nucleic acid, substantially pure polypeptides encoded by immediate early gene nucleic acid, and antibodies having specific binding affinity for a polypeptide encoded by immediate early gene nucleic acid. In addition, the invention provides cDNA libraries enriched for immediate early genes cDNAs, isolated nucleic acid derived from such cDNA libraries, and methods for treating conditions related to a deficiency in a neuron's immediate early gene responsiveness to a stimulus.
    Type: Application
    Filed: March 2, 2004
    Publication date: August 5, 2004
    Applicants: THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BASF-LYNX BIOSCIENCE AG, LYNX THERAPEUTICS, INC.
    Inventors: Paul F. Worley, Anthony Lanahan, Bernhard Goetz, Holger Hiemisch, Rohini Kuner, Sigrid Scheek, Karoly Nikolich, Eugene Zhukovsky
  • Publication number: 20040082001
    Abstract: The invention provides a method for constructing a high resolution physical map of a polynucleotide. In accordance with the invention, nucleotide sequences are determined at the ends of restriction fragments produced by a plurality of digestions with a plurality of combinations of restriction endonucleases so that a pair of nucleotide sequences is obtained for each restriction fragment. A physical map of the polynucleotide is constructed by ordering the pairs of sequences by matching the identical sequences among the pairs.
    Type: Application
    Filed: November 12, 2003
    Publication date: April 29, 2004
    Applicant: Lynx Therapeutics, Inc.
    Inventor: Stephen C. Macevicz
  • Patent number: 6720179
    Abstract: The invention provides a method for constructing a high resolution physical map of a polynucleotide. In accordance with the invention, nucleotide sequences are determined at the ends of restriction fragments produced by a plurality of digestions with a plurality of combinations of restriction endonucleases so that a pair of nucleotide sequences is obtained for each restriction fragment. A physical map of the polynucleotide is constructed by ordering the pairs of sequences by matching the identical sequences among the pairs.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: April 13, 2004
    Assignee: Lynx Therapeutics, Inc.
    Inventor: Stephen C. Macevicz
  • Publication number: 20040038283
    Abstract: Method and materials are provided for screening for genetic polymorphism in a test population of DNA fragments. Heteroduplexes are formed between members a test DNA population and their corresponding complements from a reference DNA population. Perfectly matched heteroduplexes are destroyed or separated from those containing mismatched sequences. Preferably, perfectly matched heteroduplexes are digested by a single stranded exonuclease which requires double stranded DNA as a substrate, such as E. coli exonuclease III. Amplicons are formed from mismatched heteroduplexes, preferably by extending the partially digested duplexes after treatment with exonuclease III followed by PCR amplification. The resulting amplicons are inserted into a cloning vector which is used to transform a bacterial host. After host cells are plated and allowed to form colonies, clones are picked and sequenced to identify DNA fragments containing polymorphic sequences.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 26, 2004
    Applicant: Lynx Therapeutics, Inc.
    Inventor: Sydney Brenner
  • Publication number: 20030224419
    Abstract: A data analysis system for ligation-based sequencing is provided. The system includes a base calling algorithm that may be implemented with a program of instructions (e.g., software) for determining a signature of a nucleotide sequence. A graphical user interface (GUI) enables a user to interact with and control various aspects of the base calling algorithm. The base calling algorithm and associated software may be used in connection with a technique that combines non-gel-based signature sequencing with in vitro cloning of millions of templates on separate 5 &mgr;m diameter microbeads.
    Type: Application
    Filed: April 2, 2003
    Publication date: December 4, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Kevin C. Corcoran, Sam Eletr
  • Publication number: 20030219777
    Abstract: Genes, nucleic acids, proteins, antibodies, marker sets, and arrays for the atherosclerosis susceptibility locus (ATHS) are provided. Methods of detecting atherosclerosis susceptibility and modulating cholesterol phenotype in cells are also provided.
    Type: Application
    Filed: December 17, 2002
    Publication date: November 27, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Jin Shang, Ben Bowen
  • Patent number: 6653077
    Abstract: Method and materials are provided for screening for genetic polymorphism in a test population of DNA fragments. Heteroduplexes are formed between members of a test DNA population and their corresponding complements from a reference DNA population. Perfectly matched heteroduplexes are destroyed or separated from those containing mismatched sequences. Preferably, perfectly matched heteroduplexes are digested by a single stranded exonuclease which requires double stranded DNA as a substrate, such as E. coli exonuclease III. Amplicons are formed from mismatched heteroduplexes, preferably by extending the partially digested duplexes after treatment with exonuclease III followed by PCR amplification. The resulting amplicons are inserted into a cloning vector which is used to transform a bacterial host. After host cells are plated and allowed to form colonies, clones are picked and sequenced to identify DNA fragments containing polymorphic sequences.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: November 25, 2003
    Assignee: Lynx Therapeutics, Inc.
    Inventor: Sydney Brenner
  • Patent number: 6654505
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array. A key feature of the invention is the correlation of the sequence of optical signals generated by each microparticle in the planar array during the analytical process.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: November 25, 2003
    Assignee: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin Corcoran, George Golda, Michael C. Pallas, Sydney Brenner
  • Publication number: 20030188343
    Abstract: Genes, nucleic acids and polypeptides associated with growth traits in plants are provided. Related probes, antibodies, marker sets, and arrays are provided as well as methods for predicting plant growth traits.
    Type: Application
    Filed: January 7, 2003
    Publication date: October 2, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Benjamin A. Bowen, Christian D. Haudenschild, Edward S. Buckler
  • Publication number: 20030180764
    Abstract: Genes, nucleic acids, proteins, antibodies, marker sets, and arrays are provided. Methods of detecting conditions associated with elevated cholesterol and lipid, as well as during adipogenesis, are also provided.
    Type: Application
    Filed: January 8, 2003
    Publication date: September 25, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Jin Shang, Benjamin Bowen
  • Publication number: 20030170700
    Abstract: Polynucleotides, proteins, antibodies, labeled probes, marker sets, and arrays related to secreted and cell surface proteins that are altered in response to cholesterol are provided. Methods of detecting alterations in secreted and cell surface proteins in response to alterations in cholesterol levels (exposure), modulating cholesterol phenotype in cells and for treating a subject with adverse effects of altered levels of cholesterol, e.g., elevated or high levels of cholesterol, are also provided.
    Type: Application
    Filed: January 8, 2003
    Publication date: September 11, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Jin Shang, Benjamin A. Bowen
  • Publication number: 20030166026
    Abstract: Nucleic acids, proteins, antibodies, marker sets and arrays are provided for biomarkers for breast cancer. Methods for detecting breast cancer, modulating breast cancer phenotypes in cells, and for treating a subject with breast cancer are also provided.
    Type: Application
    Filed: January 8, 2003
    Publication date: September 4, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: Laurie J. Goodman, Benjamin A. Bowen
  • Publication number: 20030077615
    Abstract: Abstract An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Application
    Filed: April 18, 2002
    Publication date: April 24, 2003
    Applicant: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin P. Corcoran, George S. Golda, Michael C. Pallas, Sydney Brenner
  • Patent number: 6518023
    Abstract: The invention provides a method for constructing a high resolution physical map of a polynucleotide. In accordance with the invention, the polynucleotide is digested successively with at least two different restriction endonucleases and the ends of the restriction fragments are sequenced after each digestion. In this manner, restriction fragments having sequenced ends are produced that can be aligned by their sequences to give a physical map of the polynucleotide. Preferably, restriction fragment ends are sequenced by massively parallel signature sequencing (MPSS), or a like parallel sequencing technique.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: February 11, 2003
    Assignee: Lynx Therapeutics, Inc.
    Inventor: Sydney Brenner
  • Patent number: 6511802
    Abstract: The invention provides a method and materials for monitoring and isolating differentially expressed genes. In accordance with the method of the invention, differently labeled populations of DNAs from sources to be compared are competitively hybridized with reference DNA cloned on solid phase supports, e.g. microparticles, to provide a differential expression library which, in the preferred embodiment, may be manipulated by fluorescence-activated cell sorting (FACS). Monitoring the relative signal intensity of the different fluorescent labels on the microparticles permits quantitative analysis of expression levels relative to the reference DNA. The invention also provides a method for identifying and isolating rare genes. Populations of microparticles having relative signal intensities of interest can be isolated by FACS and the attached DNAs identified by sequencing, such as with massively parallel signature sequencing (MPSS), or with conventional DNA sequencing protocols.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: January 28, 2003
    Assignee: Lynx Therapeutics, Inc.
    Inventors: Glenn Albrecht, Sydney Brenner, Robert B. DuBridge
  • Publication number: 20020137052
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Application
    Filed: July 17, 2001
    Publication date: September 26, 2002
    Applicant: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin P. Corcoran, George S. Golda, Sydney Brenner, Michael C. Pallas
  • Patent number: 6406848
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: June 18, 2002
    Assignee: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin Corcoran, George Golda, Michael C. Pallas, Sydney Brenner
  • Publication number: 20020061529
    Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.
    Type: Application
    Filed: July 17, 2001
    Publication date: May 23, 2002
    Applicant: Lynx Therapeutics, Inc.
    Inventors: John Bridgham, Kevin P. Corcoran, George S. Golda, Sydney Brenner, Michael C. Pallas